Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
Frequently Asked Questions
What is Market Cap of Pernix Therapeutics Holdings, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pernix Therapeutics Holdings, Inc. market cap is $403,400.00.
What is the 52-week high for Pernix Therapeutics Holdings, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pernix Therapeutics Holdings, Inc. 52 week high is $2.65 as of September 13, 2025.
What is the 52-week low for Pernix Therapeutics Holdings, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pernix Therapeutics Holdings, Inc. 52 week low is $0.017 as of September 13, 2025.
What is Pernix Therapeutics Holdings, Inc. stock price today?
Pernix Therapeutics Holdings, Inc. stock price today is $0.0289.
What was Pernix Therapeutics Holdings, Inc. stock price yesterday?
Pernix Therapeutics Holdings, Inc. stock price yesterday was $0.0213.
What is the PE ratio of Pernix Therapeutics Holdings, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pernix Therapeutics Holdings, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Pernix Therapeutics Holdings, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pernix Therapeutics Holdings, Inc. P/B ratio is -0.0020.
What is Pernix Therapeutics Holdings, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Pernix Therapeutics Holdings, Inc.'s EBITDA is 184.36.
What is the 50-day moving average of Pernix Therapeutics Holdings, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pernix Therapeutics Holdings, Inc. 50-day moving average is $0.0254.
How many employess does Pernix Therapeutics Holdings, Inc. has?
Pernix Therapeutics Holdings, Inc. has N/A employees.
